BP000315-CYT-313: Recombinant Human CD-4 (26-226 a.a.)
Source: E. coli-derived.
Applications: ELISA, Antibody Production; WB.BP000315-CYT-315: Recombinant Human CD-4 (125-202 a.a.)
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE.
Applications: Protein Assay; Antibody Production; WB.BP000315-CYT-316: Recombinant Human CD-4 (203-317 a.a.)
Source: E. coli-derived.
Applications: Protein Assay; Antibody Production; WB.BP004527: Human Pentraxin 2/SAP Protein with the C-hFc Tag
Source: The recombinant Human Pentraxin 2/SAP Protein, (amino acids His20-Val223) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human Pentraxin 2 protein with the C-hFc tag at 1 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Biotinylated Anti-Pentraxin 2 Antibody protein with the C-hFc tag with the EC50 54.5 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP004547: Mouse Pentraxin 2/SAP Protein with the C-hFc Tag
Source: The recombinant Mouse Pentraxin 2/SAP Protein, (amino acids Gln21-Asp224) fused with a hFc tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.C063P: Ruplizumab Biosimilar (Research Grade), Anti-human CD40L Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade ruplizumab biosimilar specifically binds to the human CD40L.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by ruplizumab.BP001137-C510: Recombinant Human Serum Amyloid P-Component (SAP) Protein
Source: HEK 293-derived.
Purity: > 95% by SEC-HPLC and reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 EU/ug).BP002120-PRO-453: Recombinant Human Serum Amyloid P-Component (SAP) Protein
Source: E. Coli-derived.
Applications: ELISA; MS; Western Blotting.
Purity: > 95.0% by SDS-PAGE.C066P: Toralizumab Biosimilar (Research Grade), Anti-human CD40L Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade toralizumab biosimilar specifically binds to the human CD40L / CD154 protein.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by toralizumab.